Managing haemophilia with inhibitors remains one of the most complex challenges in bleeding disorder care. Standard factor replacement therapies often become ineffective, leading to increased bleeding risk and reduced quality of life. This session explores the role of Activated Prothrombin Complex Concentrates (APCC) as a critical bypassing agent in overcoming these treatment hurdles. Join us to understand the indications, dosing strategies, and clinical considerations involved in APCC use, and how it can be integrated effectively into the management of patients with haemophilia and inhibitors.

Role of APCC in managing Haemophilia with Inhibitors

Senior Professor & Head, Pediatric Hematology division, SMS Medical College, Jaipur

Dr. Kapil Garg

1

205

2.3k

4.6

Sessions Taken

171

4.6